<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/62A9A55D-8318-4DBA-9F54-1563897BAA9B"><gtr:id>62A9A55D-8318-4DBA-9F54-1563897BAA9B</gtr:id><gtr:name>Bruker Corporation</gtr:name><gtr:address><gtr:line1>19 Fortune Drive</gtr:line1><gtr:line2>Manning Park</gtr:line2><gtr:postCode>01821</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/087B9388-D675-433D-9F2E-73DA7C8E11D1"><gtr:id>087B9388-D675-433D-9F2E-73DA7C8E11D1</gtr:id><gtr:name>Fera Science Limited</gtr:name><gtr:address><gtr:line1>17 Rochester Row</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>SW1P 1QT</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:department>Chemistry</gtr:department><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/62A9A55D-8318-4DBA-9F54-1563897BAA9B"><gtr:id>62A9A55D-8318-4DBA-9F54-1563897BAA9B</gtr:id><gtr:name>Bruker Corporation</gtr:name><gtr:address><gtr:line1>19 Fortune Drive</gtr:line1><gtr:line2>Manning Park</gtr:line2><gtr:postCode>01821</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/087B9388-D675-433D-9F2E-73DA7C8E11D1"><gtr:id>087B9388-D675-433D-9F2E-73DA7C8E11D1</gtr:id><gtr:name>Fera Science Limited</gtr:name><gtr:address><gtr:line1>17 Rochester Row</gtr:line1><gtr:city>London</gtr:city><gtr:postCode>SW1P 1QT</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E33E8B7A-75CF-4D5F-945B-BAD40BA3E224"><gtr:id>E33E8B7A-75CF-4D5F-945B-BAD40BA3E224</gtr:id><gtr:firstName>S</gtr:firstName><gtr:surname>Duckett</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/954AC80A-47B7-4F47-A3D0-7FE79078703C"><gtr:id>954AC80A-47B7-4F47-A3D0-7FE79078703C</gtr:id><gtr:firstName>Gary</gtr:firstName><gtr:surname>Green</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FG009546%2F1"><gtr:id>93584E41-CF5D-4561-822B-9F20D932DBB0</gtr:id><gtr:title>Signal Amplification in MR achieved through novel inorganic templates</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/G009546/1</gtr:grantReference><gtr:abstractText>Nuclear magnetic resonance (NMR) is arguably one of the most important methods for characterising materials in solution. It relies on the fact that certain nuclei possess the property of magnetism. Consequently when they are placed in a uniform magnetic field a precise amount of energy is required to change their magnetic orientation and this is exploited to inform on their local physical and chemical environment. The most widely recognised use of this phenomenon is found the clinical application of Magnetic Resonance Imaging (MRI) which offers unparalleled non-invasive insights into the state and health of the body. In normal conditions the behaviour of nuclei in a magnetic field creates one of the major drawbacks of both NMR and MRI : poor sensitivity. This lack of sensitivity arises because the distribution of magnetic orientations in a sample is such that the effects of only a very few of the molecules can be observed as a signal. Hyperpolarisation, the subject of this proposal, is a method for altering the magnetic distribution so that the observed signal can be increased by several orders of magnitude. Until recently effective hyperpolarisation could be achieved either by a lengthy and small scale process of transferring magnetisation from electrons to nuclei, or by using a hydrogenation reaction to transfer magnetisation from hyperpolarised nuclei in parahydrogen. Parahydrogen constitutes one quarter of naturally occurring hydrogen at room temperature and is the fuel of the space shuttle. This proposal is concerned with a new technique that allows hyperpolarisation of a substance without the need for a chemical reaction. The proposal is specifically concerned with the optimisation of the process, in terms of the chemistry of catalysis, the range of molecules that can interact with the hyperpolarised catalysts and the physical basis of the phenomenon. The proposal seeks to create a flow cell for generic use for the continuous production of hyperpolarised substances in large quantities. It is predicted that the provision of this unprecedented new method for increasing signal strengths could have wide ranging applications within chemistry and also have important implications for methods that seek to improve MRI and therefore its power as a diagnostic tool.</gtr:abstractText><gtr:fund><gtr:end>2012-07-07</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2009-01-08</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>668449</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bruker Corporation</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Bruker BioSpin</gtr:department><gtr:description>Bruker BioSpin</gtr:description><gtr:id>9F2578DB-28AC-4CA9-B479-CA539C876514</gtr:id><gtr:impact>Bruker now sell a parahydrogen generator. A beta test version of the polariser in on test with 5 international research groups.</gtr:impact><gtr:outcomeId>5457c0f7a370d7.66337813-1</gtr:outcomeId><gtr:partnerContribution>Bruker have provided access to equipment and engineering. They have provided legal support for patents</gtr:partnerContribution><gtr:piContribution>We have worked with Bruker to produce a parahydrogen generator, a device for the preparation of hyperpolarised samples and a flow probe for the detection of hyperpolarised signals</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Using SABRE to aid in the study of biologically relevant molecules</gtr:description><gtr:id>D1F2A99E-17F0-4E3A-AC12-0D9638D7D7DB</gtr:id><gtr:impact>Publications</gtr:impact><gtr:outcomeId>5457c2b6c9ccc5.12874939-1</gtr:outcomeId><gtr:partnerContribution>Knowledge and materials</gtr:partnerContribution><gtr:piContribution>We have worked with AstraZeneca on the application of SABRE methods to aid in the characterisation and probing
of small molecules of biological relevance</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>Using SABRE to aid molecular characterisation</gtr:description><gtr:id>ECEEC103-63B0-48EC-8293-7BFDECE26A38</gtr:id><gtr:impact>Publications</gtr:impact><gtr:outcomeId>5457c219b64f84.20843685-1</gtr:outcomeId><gtr:partnerContribution>They provide knowledge and materials.</gtr:partnerContribution><gtr:piContribution>GlaxoSmithKline has supported two studentships to drive forward the SABRE research. They are interested in using it to probe
pharamaceutical products</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Fera Science Limited</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Using parahydrogen to probe small molecules</gtr:description><gtr:id>A2FB4C9C-D637-4690-852E-6EFF3BD9B210</gtr:id><gtr:impact>Publicatons</gtr:impact><gtr:outcomeId>5457c35b8ba542.56819088-1</gtr:outcomeId><gtr:partnerContribution>Knowledge and Materials</gtr:partnerContribution><gtr:piContribution>We worked with FERA to develop methods to characterise trace amounts of organic materials that are relevant to food.</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>CPACT Workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E8A30FCF-3F3E-41B7-9458-41D3A6494C07</gtr:id><gtr:impact>Workshop detailing potential routes to use hyperpolarisation to aid in industrial production</gtr:impact><gtr:outcomeId>58c188bc7eb675.23282750</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wellcome Trust Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E8B80170-401A-4616-9897-CE363B4EA768</gtr:id><gtr:impact>To inform on progress towards the clinical uptake of SABRE</gtr:impact><gtr:outcomeId>58c18982928d85.25002784</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Imaging in 2020 VII, Bridging Molecular Imaging and Therapy, Jackson Hole USA.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>864E5EEC-8B5B-40D2-B207-4CDC8496FD4F</gtr:id><gtr:impact>people attended a presentation which sparked questions and discussion afterwards

15 research groups worldwide have adopted our methods</gtr:impact><gtr:outcomeId>5457cf08e69c68.92777943</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>press release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6E84C566-F07D-48AB-BB44-5F2D6F643CC4</gtr:id><gtr:impact>A press release written to share a research success

Over 30 reports in the national and international media picked up this press release. Interviews resulted on local radio.</gtr:impact><gtr:outcomeId>5457da650dcbd5.30821599</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.york.ac.uk/news-and-events/news/2009/medical-diagnosis/</gtr:url><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Using SABRE to improve NMR and MRI</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>CDD4F6ED-38E5-4D28-BF8A-0F0C1BC577FF</gtr:id><gtr:impact>Talk given in Paris</gtr:impact><gtr:outcomeId>58c18a1098f9e5.62583301</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Gordon Conference, In Vivo Magnetic Resonance</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B60FCF84-3171-4499-B50B-8DA204E5A20C</gtr:id><gtr:impact>Over 100 people attended a presentation which sparked questions and discussion afterwards 

Over 15 research groups worldwide have adopted our methods</gtr:impact><gtr:outcomeId>5457d950238a84.87095980</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.grc.org/programs.aspx?year=2014&amp;program=invivo</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk, ISMAR, Rio de Janerio, Brazil</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FC0A9977-79CE-4065-B9DC-B703DF25E105</gtr:id><gtr:impact>people attended a presentation which sparked questions and discussion afterwards

Over 15 research groups worldwide have adopted our methods</gtr:impact><gtr:outcomeId>5457cfefb05304.04529314</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Speaker, Euromar, Dublin, Eire.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0A9B604F-C2D8-4C90-AE0F-E66B34D98802</gtr:id><gtr:impact>Over 100 people attended a presentation which sparked questions and discussion afterwards 

Over 15 research groups worldwide have adopted our methods</gtr:impact><gtr:outcomeId>5457d0349b5594.25978031</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk Hyperpolarisation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>28FC6571-EABF-462A-9579-F2A2D09276FC</gtr:id><gtr:impact>Talk as part of a prize symposium</gtr:impact><gtr:outcomeId>58c18c473df082.55814494</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BioNMR workshop Weizmann Institute.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C736B46E-6F90-4697-BE6C-DA9A976F1017</gtr:id><gtr:impact>Over 50 people attended a presentation which sparked questions and discussion afterwards 

Over 15 research groups worldwide have adopted our methods</gtr:impact><gtr:outcomeId>5457d8bcd92e36.60706614</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:url>http://www.weizmann.ac.il/weizsites/bionmr/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dalton Discussion Symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2D3E1E87-5173-4527-97D0-EBCC74F3AB33</gtr:id><gtr:impact>A research talk on the use of parahydrogen enhanced NMR methods for cataysis</gtr:impact><gtr:outcomeId>58c18863c62a93.42360956</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Domino Printing Inks Visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>93D5EFE5-9266-4942-8A41-4AEABB8A712F</gtr:id><gtr:impact>A presentation was given on the potential of SABRE as a tool to aid in the analysis of printing ink solutions</gtr:impact><gtr:outcomeId>58c1846204df94.90916251</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Rank Prize Symposium</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EBAB0A68-E7DC-4556-87C7-AF1F490EEBA6</gtr:id><gtr:impact>I contributed to a workshop aimed at driving forward change in chemical detection

Over 15 research groups worldwide have adopted our methods</gtr:impact><gtr:outcomeId>5457c9d1d38669.36754828</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.rankprize.org/index.php/symposia/general</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>New scanning technology aims to achieve quicker diagnosis of disease</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>89002827-21C4-4325-802B-C74D76E17DD6</gtr:id><gtr:impact>New scanning technology aims to achieve quicker diagnosis of disease. Groundbreaking research taking place at the University of York could lead to Alzheimer's disease being diagnosed in minutes using a simple brain scan. Scientists are working on new technology that could revolutionise the way in which Magnetic Resonance Imaging (MRI) scans are used to view the molecular events behind diseases like Alzheimer's, without invasive procedure, by increasing the sensitivity of an average hospital scanner by 200,000 times.

The technology underpinning this project, SABRE (Signal Amplification by Reversible Exchange), has received a &amp;pound;3.6m Strategic Award from the Wellcome Trust to fund a team of seven post-doctoral researchers from this month.

on-going</gtr:impact><gtr:outcomeId>5457de8123b675.35675899</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.york.ac.uk/chym/news/2012/scanning/</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>iMR CDT Research Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EA2E024B-8866-4DBE-B1C8-D9E30995736C</gtr:id><gtr:impact>Presentation at CDT workshop to inform on hyperpolarisation with parahydrogen</gtr:impact><gtr:outcomeId>56c5f3f41ec0f4.07604407</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www2.warwick.ac.uk/fac/sci/physics/research/condensedmatt/imr_cdt/news_events/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Intermediary Metabolism in Cancer meeting, Dallas USA.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>700055F0-571C-47B1-AB8E-071563E42D09</gtr:id><gtr:impact>Over 100 people attended a presentation which sparked questions and discussion afterwards

Over 15 research groups worldwide have adopted our methods. This includes groups at Johns Hopkins, UT Southwestern Medical Centre, and the University Medical Center Freiburg</gtr:impact><gtr:outcomeId>5457c872c15407.66440914</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.utsouthwestern.edu/edumedia/edufiles/departments_centers/airc/annual-symposium-202010.pdf</gtr:url><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NMR discussion group meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5A832C9E-0E73-4593-AC17-5ADBEC82EA9C</gtr:id><gtr:impact>Local organiser and speaker at a meeting focussed on low field NMR</gtr:impact><gtr:outcomeId>58c189335ee806.96905611</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>press release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EE2C2DF4-466F-45D5-9104-8D3DA0DF5DCC</gtr:id><gtr:impact>Information shared with public

Research progresses towards clinical use</gtr:impact><gtr:outcomeId>5457db381926f3.23947924</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.york.ac.uk/news-and-events/news/2010/research/hyperpolarisation/</gtr:url><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>New national centre to transform medical imaging</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1B767339-5B2C-43B2-A703-2502694F9D39</gtr:id><gtr:impact>Detail new funding stream

A new &amp;pound;6.8 million research centre based across two Yorkshire universities will aim to transform diagnosis and treatment of patients suffering from cancer, heart disease and musculoskeletal diseases with the help of new medical imaging facilities to be created at Leeds Teaching Hospitals and the University of York.</gtr:impact><gtr:outcomeId>5457ddaf587fa3.72206078</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.york.ac.uk/news-and-events/news/2014/medical-imaging-centre/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>German-UK MR Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B9657251-44C9-45AF-A566-E626E941D25F</gtr:id><gtr:impact>Invited key-note talk at international meeting.</gtr:impact><gtr:outcomeId>56c5f1d5455bf2.97984687</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.chemie.tu-darmstadt.de/gdch-fgmr2015/fgmr_2015/index.en.jsp</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>5th Australian Organometallics Meeting (Sydney)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>90E0BA4E-1590-4F87-B9B5-6BAD0AF21D5C</gtr:id><gtr:impact>70 academics, postdocs and research students attended a research presentation, which sparked questions and discssion afterwards

Subsequent joint ARC grant with B Messerle (Sydney)</gtr:impact><gtr:outcomeId>5457c5b0a05252.44996066</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Opening National Centre of Hyperpolarised MRI</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>5A1A5466-1F96-4383-93A9-DD85A5BEDB32</gtr:id><gtr:impact>Scientific talk on developments in SABRE hyperpolarisation.</gtr:impact><gtr:outcomeId>58c18d03e37667.08652013</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>York Hyperpolarisation Symposium (2 Day)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EEB327E7-B810-4276-8E59-79789649920B</gtr:id><gtr:impact>Series of 20 talks over 2 days</gtr:impact><gtr:outcomeId>58c18c85d1fbe9.93377295</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Local Workshop for EUROPOL (ITN)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>24B03164-D78A-476D-9767-3A2D9228CC47</gtr:id><gtr:impact>A workshop on hyperpolarisation methods based on parahydrogen.</gtr:impact><gtr:outcomeId>58c185ca036d06.57905959</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk Cambridge Synthesis and Applications of Labelled Compounds</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>910383DB-067F-467A-98A8-A98AC2807EE6</gtr:id><gtr:impact>Talk within international meeting</gtr:impact><gtr:outcomeId>58c18be89b33d6.78037286</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Euromar, Florence, Italy.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>01276D7B-56D2-46EA-AF79-AFC5F43329D6</gtr:id><gtr:impact>Over 100 people attended a presentation which sparked questions and discussion afterwards

Over 15 research groups worldwide have adopted our methods</gtr:impact><gtr:outcomeId>5457c904eb2a25.02096540</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.euromar.org/about.html</gtr:url><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>4th International Metabolic Imaging Workshop</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BE607904-0A51-40CD-966A-AB7A6524C7E6</gtr:id><gtr:impact>A presentation on parahydrogen based methods to improve NMR and MRI</gtr:impact><gtr:outcomeId>58c187fe03f1e0.67130573</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>7th Conference on Field Cycling NMR Relaxometry</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F24D278A-6428-47D1-B2E2-E0D3523C609B</gtr:id><gtr:impact>People attended a presentation which sparked questions and discussion afterwards

Other researchers now use our methods</gtr:impact><gtr:outcomeId>5457ce57434c47.65631186</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.ffcrelax.com/ffcrelax/ffc2011/mainpage.php?folder=program&amp;page=index.php</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Hyperpolarised MRI workshop</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A3939C3F-6426-4397-8136-6F4CB13D5AD1</gtr:id><gtr:impact>Workshop to consider progress in hyperpolarisation that will lead to clinical use</gtr:impact><gtr:outcomeId>56c5f0f32a3f88.01123536</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Experimental Nuclear Magnetic Resonance Conference (ENC), Daytona Beach USA.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3D324A42-F977-4D2D-9F33-B2C7AB3D13AA</gtr:id><gtr:impact>Over 100 people attended a presentation which sparked questions and discussion afterwards

Over 15 research groups worldwide have adopted our methods</gtr:impact><gtr:outcomeId>5457c71deb8311.71438396</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.enc-conference.org/</gtr:url><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Huddersfield Hyperpolarisation Meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FD16C79B-6EB5-4A3B-824E-4431B9D2DFDA</gtr:id><gtr:impact>Series of presentations detailing aspects of hyperpolarisation</gtr:impact><gtr:outcomeId>58c18b99801022.58297921</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wellcome Trust, Next Generation Brain Imaging Technologies, London, UK.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C9EBD2FF-283D-48BF-89C7-B0A712B8C2C5</gtr:id><gtr:impact>people attended a presentation which sparked questions and discussion afterwards

Funding awarded to take methods forward.</gtr:impact><gtr:outcomeId>5457cf895004c4.06526927</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>4360000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Capital Awards Scheme</gtr:description><gtr:end>2016-11-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>092506/B/10/Z</gtr:fundingRef><gtr:id>E817C9FF-81E3-4842-B31C-1A89C9D6F5B0</gtr:id><gtr:outcomeId>5ee181b25ee181c6</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>65000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GlaxoSmithKline (GSK)</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>6D587EE5-7C98-46F6-B3F4-858533DC8D29</gtr:id><gtr:outcomeId>r-9628898892.206045068bdeea</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Strategic Awards Scheme</gtr:description><gtr:end>2017-11-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>098335/Z/12/Z</gtr:fundingRef><gtr:id>D6E272A2-DEF6-429A-94CD-A9FB29677C8F</gtr:id><gtr:outcomeId>5ee150b65ee150ca</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>65000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GlaxoSmithKline (GSK)</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:fundingRef>STU029361</gtr:fundingRef><gtr:id>4593B982-3F32-4D04-B1E6-D173C3D9062C</gtr:id><gtr:outcomeId>5ec2054e5ec20562</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Our findings have been used by around 15 research groups worldwide. They have led to the production of a parahydrogen generator which is sold by Bruker BioSpin. Bruker have produced additional equipment which is now undergoing beta-test.</gtr:description><gtr:firstYearOfImpact>2011</gtr:firstYearOfImpact><gtr:id>DB92EC46-87A8-40CB-9F0F-8083318F41ED</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>544fe508554ef5.13658539</gtr:outcomeId><gtr:sector>Chemicals,Healthcare,Manufacturing, including Industrial Biotechology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The invention relates to a device (1, 21, 31, 41, 64) for the preparation and measurement of a nuclear spin resonance (NMR) measurement sample (10), including-a flow-through NMR probehead (2), with a first tube (3) and a second tube (14) each for the supply and removal of a liquid NMR measurement sample (10),-at least one chamber (4, 22, 32) which is connected to one of the tubes (3, 14),-a sample inlet (5) for introducing the liquid measurement sample (10) into the device (1, 21, 31, 41, 64), wherein at least one chamber (4, 22, 32) has at least one connection for increasing (9, 24, 25, 42, 43, 46, 47) and releasing (8, 23, 27, 48 a , 48 b) the gas pressure, and in which at least one chamber (4, 22, 32) comprises means for mixing the liquid measurement sample (10) contained in the chamber (4, 22, 32) with a gas With the inventive device it is possible to reduce the measurement sample consumption when doing an NMR spectroscopic measurement on liquid measurement samples to which spin order can be catalytically transferred.</gtr:description><gtr:grantRef>EP/G009546/1</gtr:grantRef><gtr:id>8AA22FD2-94EA-4E29-890A-DF73018D6379</gtr:id><gtr:impact>This has been licensed to Bruker BioSpin</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>544fe11bb01846.10776427</gtr:outcomeId><gtr:patentId>US 8766631 B2</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>NMR measurement apparatus with flow-through probehead</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>An NMR experiment on hyperpolarizable magnetic nuclei of substrate molecules in a living human or animal body, involves polarizing the substrate molecules by non-hydrogenating para-hydrogen induced polarization (=NH-PHIP) into a singlet/pseudo singlet state in low magnetic field and injecting the substrate molecules into the living body, the body or a part thereof being previously located inside a magnet at low magnetic field. The magnet is switched on to high magnetic field, and in at least part of the substrate molecules, the singlet state/pseudo singlet state is converted into observable magnetization. An MRI or MRS measurement is carried out with the living body or the part thereof, collecting data from the substrate molecules. The NMR experiment is well applicable on hyperpolarized nuclei within a patient, with reduced losses of magnetization due to relaxation processes.</gtr:description><gtr:grantRef>EP/G009546/1</gtr:grantRef><gtr:id>1254D0E3-3DDC-46E2-B1A0-1FDD60FD024F</gtr:id><gtr:impact>We hope that this patent will be used by Bruker BioSpin.</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>544fe034579c28.14380308</gtr:outcomeId><gtr:patentId>8825132</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Field Cycling Method for Magnetic Resonance</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>An NMR method is presented having enhanced sensitivity on a compound comprising hyperpolarizable nuclei, in particular applying enhanced PHIP. Polarization is thereby transferred from a prepared fluid, which is enriched with symmetric molecules of a particular spin state (e.g. para-hydrogen enriched), directly to the hyperpolarizable nuclei of a compound, without altering the chemical identity of the compound in this process. Spin transfer is achieved using a template having sites of ordered environment, and the fluid and the compound are brought together in the presence of the template. Polarization transfer to the hyperpolarizable nuclei of the compound is thereby easier to perform and can be applied to a broader scope of compounds.</gtr:description><gtr:grantRef>EP/G009546/1</gtr:grantRef><gtr:id>D20E1DA8-C240-44C5-B829-1031B0797B9A</gtr:id><gtr:impact>This product has been licensed to Bruker BioSpin</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>544fe0ba7c3ae5.99475997</gtr:outcomeId><gtr:patentId>US 8154284 B2</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Hyperpolaritzation of compounds for NMR, in particular by means of PHIP</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>There is described a method of selective observation of non-hydrogenative para- hydrogen induced polarisation (NH-PHIP) as enhanced magnetic resonance signals which comprises separating the thermal and longitudinal spin order states. There is also described a template comprising [Ir(COD)(NHC)(Py)]+, and analogues thereof, for use in a PHIP magnetic resonance technique and a method for its preparation.</gtr:description><gtr:grantRef>EP/G009546/1</gtr:grantRef><gtr:id>26BBF9F5-A556-4858-8E30-0E5BB2653A4D</gtr:id><gtr:impact>We are working with Bruker BipSpin on the application.</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>544fe17c2ddab9.46712883</gtr:outcomeId><gtr:patentId>WO 2010067076</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Pulse sequencing with hyperpolarisable nuclei</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>Scientists at the University of York have developed new technology which could dramatically cut scanning times for important health tests and increase the accuracy of the results.

They have discovered a way of making Magnetic Resonance Imaging (MRI) scanners, extensively used in hospitals, and Nuclear Magnetic Resonance (NMR) machines employed in chemistry research far more sensitive than was previously possible.

Research conducted at the York NMR Centre and the York Neuroimaging Centre has uncovered/produced/developed a new technique which allows molecules to be much more easily detected in a scanner without changing their chemical structure. This is achieved by manipulating a fundamental property of atoms termed 'spin'. 

The key advantage over previous technologies is that this can be achieved without the use of a chemical reaction or having to cool the molecules down to very low temperatures. This will allow much easier and cheaper implementation in hospitals or in the laboratory.

We have shown that the gain in sensitivity is so great that data can be acquired in seconds rather than months. 

This has very positive implications for faster diagnosis for patients in the future.

The technique could ultimately replace current clinical imaging technologies that depend on the use of radioactive substances or heavy metals.&amp;quot;</gtr:description><gtr:exploitationPathways>They have the potential to improve NMR or MRI</gtr:exploitationPathways><gtr:id>BE2E7A7C-42E1-44B7-AC97-C27EAF29B0ED</gtr:id><gtr:outcomeId>544fe5f4e78fa5.46367918</gtr:outcomeId><gtr:sectors><gtr:sector>Chemicals,Healthcare,Manufacturing, including Industrial Biotechology</gtr:sector></gtr:sectors><gtr:url>https://www.york.ac.uk/chym/</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>We worked with Bruker BioSpin to produce a device to make parahydrogen</gtr:description><gtr:id>87C33CE7-1364-45D5-9057-73DE06AF5116</gtr:id><gtr:impact>The device is being used by a number of researchers to help support hyperpolarisation studies aligned to clinical MRI.</gtr:impact><gtr:outcomeId>544fe3ec1aa571.42141390</gtr:outcomeId><gtr:title>Parahydrogen Generator</gtr:title><gtr:type>New/Improved Technique/Technology</gtr:type><gtr:url>http://www.bruker.com/products/mr/nmr/accessories/hyperpolarization/parahydrogen-generator/overview.html</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>HYPERNETICS IMAGING LIMITED</gtr:companyName><gtr:description>Currently company holds the patents associated with SABRE and seeks to develop their use.</gtr:description><gtr:id>06236804-4443-45DA-82EF-8EC96E00045D</gtr:id><gtr:impact>Currently seeking investment</gtr:impact><gtr:outcomeId>5457e1c2097c56.89598411</gtr:outcomeId><gtr:yearCompanyFormed>2013</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>28186E99-FC49-4FD3-86B7-69ABB88B39F0</gtr:id><gtr:title>Utilization of SABRE-derived hyperpolarization to detect low-concentration analytes via 1D and 2D NMR methods.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec635d5532f80cf2c544fe67734ec2be"><gtr:id>ec635d5532f80cf2c544fe67734ec2be</gtr:id><gtr:otherNames>Lloyd LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>541b15d45ae799.53980682</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>102FF1CE-09EF-4676-BEFC-A754EBC58AF7</gtr:id><gtr:title>A hyperpolarized equilibrium for magnetic resonance.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91541c676c18803ed0744072296de638"><gtr:id>91541c676c18803ed0744072296de638</gtr:id><gtr:otherNames>H?vener JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>541a8e6a048022.48078323</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E288E9C5-5723-48BF-9232-C1DD2B4F7BCC</gtr:id><gtr:title>Utilisation of water soluble iridium catalysts for signal amplification by reversible exchange.</gtr:title><gtr:parentPublicationTitle>Dalton transactions (Cambridge, England : 2003)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a43367fbc987f1ec954721327a15270d"><gtr:id>a43367fbc987f1ec954721327a15270d</gtr:id><gtr:otherNames>Fekete M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1477-9226</gtr:issn><gtr:outcomeId>56c5ff37ebce02.81967697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D5D529B-B091-4F85-AFC0-9F1899B942BE</gtr:id><gtr:title>Deactivation of signal amplification by reversible exchange catalysis, progress towards in vivo application.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/372086874c5d7858c3d4657cd456c1fc"><gtr:id>372086874c5d7858c3d4657cd456c1fc</gtr:id><gtr:otherNames>Mewis RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>56c5ff38495744.11963907</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B67389B-51AC-44E0-9CDC-A70784975ADF</gtr:id><gtr:title>Hyperpolarisation through reversible interactions with parahydrogen</gtr:title><gtr:parentPublicationTitle>Catal. Sci. Technol.</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2de7dcc4cef09b9436fe5c968c43c627"><gtr:id>2de7dcc4cef09b9436fe5c968c43c627</gtr:id><gtr:otherNames>Lloyd L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>doi_55f95c95ce5d5f26</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A85CDC85-CE01-450F-B66C-973D857BECBB</gtr:id><gtr:title>A parahydrogen based NMR study of Pt catalysed alkyne hydrogenation.</gtr:title><gtr:parentPublicationTitle>Dalton transactions (Cambridge, England : 2003)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/34afbfeb398b8ba29344f817831c575c"><gtr:id>34afbfeb398b8ba29344f817831c575c</gtr:id><gtr:otherNames>Boutain M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1477-9226</gtr:issn><gtr:outcomeId>doi_53d02c02c62e9946</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CB60CF7-A4EC-4F28-9FC7-F849DCBF90BF</gtr:id><gtr:title>Application of parahydrogen induced polarization techniques in NMR spectroscopy and imaging.</gtr:title><gtr:parentPublicationTitle>Accounts of chemical research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92ffafa9a1798a7879d22ff5e577cb03"><gtr:id>92ffafa9a1798a7879d22ff5e577cb03</gtr:id><gtr:otherNames>Duckett SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0001-4842</gtr:issn><gtr:outcomeId>541b16e24cad77.01867824</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BEE8C4FD-B00B-44EF-9D30-5A55DCCC9471</gtr:id><gtr:title>Utilization of SABRE-Derived Hyperpolarization To Detect Low-Concentration Analytes via 1D and 2D NMR Methods</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38d1e94652f26c4bb4ec76e3d1d319ae"><gtr:id>38d1e94652f26c4bb4ec76e3d1d319ae</gtr:id><gtr:otherNames>n/a n/a (Final Report data)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>r_3708164775035c6ac0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>800A9D9F-D819-4393-B678-B22A9042278F</gtr:id><gtr:title>A continuous-flow, high-throughput, high-pressure parahydrogen converter for hyperpolarization in a clinical setting.</gtr:title><gtr:parentPublicationTitle>NMR in biomedicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91541c676c18803ed0744072296de638"><gtr:id>91541c676c18803ed0744072296de638</gtr:id><gtr:otherNames>H?vener JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0952-3480</gtr:issn><gtr:outcomeId>541b16070c00b7.45092856</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDEA8C26-6522-42EC-AC27-26F1B495B597</gtr:id><gtr:title>The reaction of an iridium PNP complex with parahydrogen facilitates polarisation transfer without chemical change.</gtr:title><gtr:parentPublicationTitle>Dalton transactions (Cambridge, England : 2003)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd063d1246c4ef7fc0641cb70a688b0d"><gtr:id>dd063d1246c4ef7fc0641cb70a688b0d</gtr:id><gtr:otherNames>Holmes AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1477-9226</gtr:issn><gtr:outcomeId>56c5ff386e2a94.06099919</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6133A1C3-7E6D-44D1-B208-8EA6F026E045</gtr:id><gtr:title>Facing and Overcoming Sensitivity Challenges in Biomolecular NMR Spectroscopy.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2acb69b4403de66d82ef11cfd0570179"><gtr:id>2acb69b4403de66d82ef11cfd0570179</gtr:id><gtr:otherNames>Ardenkjaer-Larsen JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>56c5ff907ef319.32251747</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74093517-4EB1-4766-A3A5-681E69EABC0F</gtr:id><gtr:title>Toward biocompatible nuclear hyperpolarization using signal amplification by reversible exchange: quantitative in situ spectroscopy and high-field imaging.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91541c676c18803ed0744072296de638"><gtr:id>91541c676c18803ed0744072296de638</gtr:id><gtr:otherNames>H?vener JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn><gtr:outcomeId>541a8e69cc2441.50788078</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCDCDD89-D780-42C9-8A78-A9CDD4A830AB</gtr:id><gtr:title>Correction to Iridium(III) Hydrido N-Heterocyclic Carbene&amp;acirc;??Phosphine Complexes as Catalysts in Magnetization Transfer Reactions</gtr:title><gtr:parentPublicationTitle>Inorganic Chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a43367fbc987f1ec954721327a15270d"><gtr:id>a43367fbc987f1ec954721327a15270d</gtr:id><gtr:otherNames>Fekete M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>541b16553f3bc4.78202621</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BD4C565-D36B-46AA-8637-3B623CF7ECB8</gtr:id><gtr:title>Iridium N-heterocyclic carbene complexes as efficient catalysts for magnetization transfer from para-hydrogen.</gtr:title><gtr:parentPublicationTitle>Journal of the American Chemical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92566ed87daa534df0a5f27f2be15f14"><gtr:id>92566ed87daa534df0a5f27f2be15f14</gtr:id><gtr:otherNames>Cowley MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-7863</gtr:issn><gtr:outcomeId>541b17464e1571.83866536</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EF63932-F3CB-43AB-B480-9D6D09407B57</gtr:id><gtr:title>Probing signal amplification by reversible exchange using an NMR flow system.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in chemistry : MRC</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/372086874c5d7858c3d4657cd456c1fc"><gtr:id>372086874c5d7858c3d4657cd456c1fc</gtr:id><gtr:otherNames>Mewis RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0749-1581</gtr:issn><gtr:outcomeId>541a8e69970c14.11097957</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2867054E-0E3B-4BF1-AF9B-EEB9DDE64E6C</gtr:id><gtr:title>The theory and practice of hyperpolarization in magnetic resonance using parahydrogen.</gtr:title><gtr:parentPublicationTitle>Progress in nuclear magnetic resonance spectroscopy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/974200e05f730cdc6460e18bfbe150d8"><gtr:id>974200e05f730cdc6460e18bfbe150d8</gtr:id><gtr:otherNames>Green RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0079-6565</gtr:issn><gtr:outcomeId>541b1632cf02e2.51074390</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8AD7A0A-8295-47A6-883E-63C21A93A01B</gtr:id><gtr:title>Investigating pyridazine and phthalazine exchange in a series of iridium complexes in order to define their role in the catalytic transfer of magnetisation from-hydrogen.</gtr:title><gtr:parentPublicationTitle>Chemical science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29cc1e04eca8ec0aab46331426640051"><gtr:id>29cc1e04eca8ec0aab46331426640051</gtr:id><gtr:otherNames>Appleby KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-6520</gtr:issn><gtr:outcomeId>5675fe0542fb8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AC74E53-7465-409C-A83C-03CC4C6A2992</gtr:id><gtr:title>Selective detection of hyperpolarized NMR signals derived from para-hydrogen using the Only Para-hydrogen SpectroscopY (OPSY) approach.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance (San Diego, Calif. : 1997)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17abb2d6c4bc453c37ae9532472ff2b5"><gtr:id>17abb2d6c4bc453c37ae9532472ff2b5</gtr:id><gtr:otherNames>Aguilar JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1090-7807</gtr:issn><gtr:outcomeId>m_964149612213843b78</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12B62EC9-232E-4D84-B0BC-C51D6266FC5F</gtr:id><gtr:title>A theoretical basis for spontaneous polarization transfer in non-hydrogenative parahydrogen-induced polarization.</gtr:title><gtr:parentPublicationTitle>The Journal of chemical physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af009c7e0e21409b0513ccf9161bb075"><gtr:id>af009c7e0e21409b0513ccf9161bb075</gtr:id><gtr:otherNames>Adams RW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9606</gtr:issn><gtr:outcomeId>541b181966f336.79014410</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C221400B-DC19-468B-A1BE-945A8088D4A9</gtr:id><gtr:title>Improving the hyperpolarization of (31)P nuclei by synthetic design.</gtr:title><gtr:parentPublicationTitle>The journal of physical chemistry. B</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6a3f6b96a467ebc77c42ca9a1df3181"><gtr:id>c6a3f6b96a467ebc77c42ca9a1df3181</gtr:id><gtr:otherNames>Burns MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1520-5207</gtr:issn><gtr:outcomeId>56c5ff38240bf3.72675785</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CD6C77B-911D-411B-89B4-E43994D4B515</gtr:id><gtr:title>Para-hydrogen induced polarization without incorporation of para-hydrogen into the analyte.</gtr:title><gtr:parentPublicationTitle>Inorganic chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52f0fd187908d8277dad42746ff16906"><gtr:id>52f0fd187908d8277dad42746ff16906</gtr:id><gtr:otherNames>Atkinson KD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0020-1669</gtr:issn><gtr:outcomeId>541b17c769be41.61660070</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E142AFF1-B2E1-4955-8195-FF29F8891B45</gtr:id><gtr:title>Improving NMR and MRI sensitivity with parahydrogen.</gtr:title><gtr:parentPublicationTitle>Topics in current chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/92ffafa9a1798a7879d22ff5e577cb03"><gtr:id>92ffafa9a1798a7879d22ff5e577cb03</gtr:id><gtr:otherNames>Duckett SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:isbn>978-3-642-39727-1</gtr:isbn><gtr:issn>0340-1022</gtr:issn><gtr:outcomeId>541b16b4c8ab45.36658111</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDCBC909-CE2A-4500-8ED0-98DAB8CDCF3D</gtr:id><gtr:title>Strategies for the hyperpolarization of acetonitrile and related ligands by SABRE.</gtr:title><gtr:parentPublicationTitle>The journal of physical chemistry. B</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/372086874c5d7858c3d4657cd456c1fc"><gtr:id>372086874c5d7858c3d4657cd456c1fc</gtr:id><gtr:otherNames>Mewis RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1520-5207</gtr:issn><gtr:outcomeId>doi_55f95c95ce453e50</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBD4B23D-CE56-489C-8408-366CA6714999</gtr:id><gtr:title>Activation of a (cyclooctadiene) rhodium(I) complex supported by a chiral ferrocenyl phosphine thioether ligand for hydrogenation catalysis: a combined parahydrogen NMR and DFT study.</gtr:title><gtr:parentPublicationTitle>Dalton transactions (Cambridge, England : 2003)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41d10eee99f0fa1a380e8daab9d74c18"><gtr:id>41d10eee99f0fa1a380e8daab9d74c18</gtr:id><gtr:otherNames>Kozinets EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1477-9226</gtr:issn><gtr:outcomeId>doi_55f95c95ce53fdb7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41ED23A9-F2E1-4685-9B57-3848C40D1140</gtr:id><gtr:title>Optimization of SABRE for polarization of the tuberculosis drugs pyrazinamide and isoniazid.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance (San Diego, Calif. : 1997)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21470628365849f3a14f09f423d3e77e"><gtr:id>21470628365849f3a14f09f423d3e77e</gtr:id><gtr:otherNames>Zeng H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1090-7807</gtr:issn><gtr:outcomeId>doi_55f95c95ce3ba4d8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EFC82830-BB3E-4A91-9E92-94672A6B8BDA</gtr:id><gtr:title>Selective detection of hyperpolarized NMR signals derived from para-hydrogen using the Only Para-hydrogen SpectroscopY (OPSY) approach.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance (San Diego, Calif. : 1997)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17abb2d6c4bc453c37ae9532472ff2b5"><gtr:id>17abb2d6c4bc453c37ae9532472ff2b5</gtr:id><gtr:otherNames>Aguilar JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1090-7807</gtr:issn><gtr:outcomeId>541b17f44e97d4.16593688</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E78B411-20C9-4B45-96F8-740DBD71932C</gtr:id><gtr:title>Iridium(III) hydrido N-heterocyclic carbene-phosphine complexes as catalysts in magnetization transfer reactions.</gtr:title><gtr:parentPublicationTitle>Inorganic chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a43367fbc987f1ec954721327a15270d"><gtr:id>a43367fbc987f1ec954721327a15270d</gtr:id><gtr:otherNames>Fekete M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0020-1669</gtr:issn><gtr:outcomeId>541b1673af2425.84581100</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FC7E9C0-6D4C-4208-9799-4E3790D4F312</gtr:id><gtr:title>Catalytic Transfer of Magnetism using a Neutral Iridium Phenoxide Complex.</gtr:title><gtr:parentPublicationTitle>Organometallics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26a3c0754a83521287de942543016943"><gtr:id>26a3c0754a83521287de942543016943</gtr:id><gtr:otherNames>Ruddlesden AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0276-7333</gtr:issn><gtr:outcomeId>5675fdff84b06</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/G009546/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>863FC58A-7217-42EA-B076-663F2D770BB8</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Chemical measurement</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>60EBB420-734E-4DB5-B0F2-65A1115A27F8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Chemical synthesis</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>FB535BD0-E265-4C0A-8532-32DCB83A3951</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Tools, technologies &amp; methods</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>98EA7556-1427-44F9-84F3-BF99B7207302</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Analytical Science</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>0B9701E7-D17F-4963-82DA-B3926A65B50A</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Biological &amp; Medicinal Chem.</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>1820CCC5-B4C4-47E9-B81F-8F49AC606F0E</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Chemical Structure</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>454398F2-57A6-4959-8845-0F248CF4D5C4</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Chemical Synthetic Methodology</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>